Statistics at a Glance

At a Glance

Estimated New Cases in 2019 8,110

% of All New Cancer Cases 0.5%

Estimated Deaths in 2019 1,000

% of All Cancer Deaths 0.2%

Percent Surviving
5 Years

86.6% 2009-2015
Year New Cases - SEER 9 New Cases - SEER 13 Deaths - U.S. Percent Surviving 5 Years - SEER 9
Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend Observed Modeled Trend
1975 3.09 2.99 - - 1.31 1.29 70.15% 71.13%
1976 2.76 2.98 - - 1.17 1.21 73.44% 71.85%
1977 2.98 2.97 - - 1.14 1.13 72.83% 72.56%
1978 2.80 2.97 - - 1.06 1.06 72.56% 73.24%
1979 2.93 2.96 - - 0.97 0.99 69.67% 73.92%
1980 2.77 2.95 - - 0.98 0.95 73.60% 74.58%
1981 2.92 2.95 - - 0.93 0.92 74.71% 75.23%
1982 2.92 2.94 - - 0.88 0.89 71.56% 75.86%
1983 3.02 2.94 - - 0.85 0.86 77.06% 76.48%
1984 3.06 2.93 - - 0.86 0.83 77.91% 77.09%
1985 2.98 2.92 - - 0.77 0.80 78.97% 77.68%
1986 2.73 2.92 - - 0.78 0.77 78.74% 78.26%
1987 3.04 2.91 - - 0.74 0.74 78.23% 78.83%
1988 3.10 2.91 - - 0.67 0.72 79.91% 79.38%
1989 3.06 2.90 - - 0.71 0.69 79.94% 79.93%
1990 3.06 2.89 - - 0.66 0.67 81.13% 80.46%
1991 3.03 2.89 - - 0.65 0.64 80.59% 80.97%
1992 2.87 2.88 2.74 2.64 0.65 0.62 84.26% 81.48%
1993 2.86 2.88 2.75 2.65 0.61 0.60 80.06% 81.97%
1994 2.85 2.87 2.66 2.67 0.56 0.58 83.36% 82.45%
1995 2.77 2.87 2.61 2.68 0.55 0.56 82.44% 82.92%
1996 2.86 2.86 2.69 2.69 0.53 0.54 83.48% 83.38%
1997 2.82 2.85 2.68 2.70 0.53 0.52 87.29% 83.83%
1998 2.80 2.85 2.71 2.72 0.48 0.50 85.04% 84.27%
1999 2.86 2.84 2.80 2.73 0.51 0.49 83.83% 84.69%
2000 2.82 2.84 2.64 2.74 0.46 0.48 86.62% 85.11%
2001 2.57 2.83 2.62 2.75 0.47 0.47 85.38% 85.51%
2002 2.96 2.82 2.74 2.77 0.47 0.46 85.37% 85.91%
2003 2.72 2.82 2.67 2.78 0.46 0.45 87.72% 86.29%
2004 2.95 2.90 2.80 2.79 0.43 0.44 86.18% 86.67%
2005 3.02 2.99 2.83 2.81 0.42 0.43 88.70% 87.04%
2006 3.00 3.08 2.84 2.82 0.44 0.42 88.46% 87.39%
2007 3.18 3.03 3.00 2.83 0.41 0.41 88.74% 87.74%
2008 2.96 2.98 2.78 2.78 0.37 0.40 90.62% 88.08%
2009 2.94 2.92 2.76 2.74 0.40 0.39 85.74% 88.41%
2010 2.79 2.87 2.71 2.69 0.38 0.37 86.91% 88.73%
2011 2.73 2.82 2.60 2.64 0.36 0.36 89.75% 89.04%
2012 2.72 2.77 2.57 2.60 0.34 0.34 - 89.35%
2013 2.66 2.72 2.49 2.55 0.32 0.33 - 89.65%
2014 2.81 2.67 2.62 2.51 0.31 0.31 - 89.94%
2015 2.64 2.63 2.41 2.47 0.31 0.30 - 90.22%
2016 2.59 2.58 2.45 2.42 0.27 0.28 - 90.49%

Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.


Number of New Cases and Deaths per 100,000: The number of new cases of Hodgkin lymphoma was 2.7 per 100,000 men and women per year. The number of deaths was 0.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2012-2016 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 0.2 percent of men and women will be diagnosed with Hodgkin lymphoma at some point during their lifetime, based on 2014-2016 data.

Prevalence of This Cancer: In 2016, there were an estimated 210,974 people living with Hodgkin lymphoma in the United States.

Survival Statistics

How Many People Survive 5 Years Or More after Being Diagnosed with Hodgkin Lymphoma?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.

86.6%

Percent Surviving
5 Years

86.6%

Based on data from SEER 18 2009-2015. Gray figures represent those who have died from Hodgkin lymphoma. Green figures represent those who have survived 5 years or more.

Additional Information

Survival by Stage

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. For Hodgkin lymphoma, 14.9% are diagnosed at stage I. The 5-year survival for stage I Hodgkin lymphoma is 91.6%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Hodgkin Lymphoma
Stage Percent of Cases 5-Year Relative Survival
Stage I
Confined to Single Region
15% 91.6%
Stage II
Involving Mulitple Regions
39% 93.5%
Stage III
Spread to Both Sides of Diaphragm
21% 82.9%
Stage IV
Diffuse or Disseminated Involvement
20% 73.5%
Unknown
Unstaged
4% 83.0%

SEER 18 2009-2015, All Races, Both Sexes by Ann Arbor Stage

Additional Information

Number of New Cases and Deaths

How Common Is This Cancer?

Compared to other cancers, Hodgkin lymphoma is rare.

Rank Common Types of Cancer Estimated New
Cases 2019
Estimated
Deaths 2019
1. Breast Cancer (Female) 268,600 41,760
2. Lung and Bronchus Cancer 228,150 142,670
3. Prostate Cancer 174,650 31,620
4. Colorectal Cancer 145,600 51,020
5. Melanoma of the Skin 96,480 7,230
6. Bladder Cancer 80,470 17,670
7. Non-Hodgkin Lymphoma 74,200 19,970
8. Kidney and Renal Pelvis Cancer 73,820 14,770
9. Uterine Cancer 61,880 12,160
10. Leukemia 61,780 22,840
- - -
26. Hodgkin Lymphoma 8,110 1,000

Hodgkin lymphoma represents 0.5% of all new cancer cases in the U.S.

0.5%

In 2019, it is estimated that there will be 8,110 new cases of Hodgkin lymphoma and an estimated 1,000 people will die of this disease.

Who Gets This Cancer?

Hodgkin lymphoma is more common among young adults and among men than women. It can occur in both adults and children; however, treatment for adults may be different than treatment for children. Hodgkin lymphoma may also occur in patients who have acquired immunodeficiency syndrome (AIDS); these patients require special treatment. The number of new cases of Hodgkin lymphoma was 2.7 per 100,000 men and women per year based on 2012-2016 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Hodgkin Lymphoma
Males
All Races 3.0
White 3.1
Black 3.1
Asian/Pacific Islander 1.5
American Indian/Alaska Native 1.5
Hispanic 2.7
Non-Hispanic 3.2
Females
All Races 2.3
White 2.5
Black 2.3
Asian/Pacific Islander 1.0
American Indian/Alaska Native 1.2
Hispanic 2.1
Non-Hispanic 2.5

SEER 21 2012-2016, Age-Adjusted

Percent of New Cases by Age Group: Hodgkin Lymphoma
Age Range Percent of New Cases
<20 12.0%
20-34 31.5%
35-44 13.7%
45-54 12.7%
55-64 12.1%
65-74 9.7%
75-84 6.2%
>84 2.1%

Hodgkin lymphoma is most frequently diagnosed among people aged 20-34.

Median Age
At Diagnosis

39

SEER 21 2012-2016, All Races, Both Sexes

Who Dies From This Cancer?

The number of deaths was 0.3 per 100,000 men and women per year based on 2012-2016 deaths.

Number of Deaths per 100,000 Persons by Race/Ethnicity & Sex: Hodgkin Lymphoma
Males
All Races 0.4
White 0.4
Black 0.4
Asian/Pacific Islander 0.2
American Indian/Alaska Native Not Shown, <16 cases
Hispanic 0.5
Non-Hispanic 0.4
Females
All Races 0.2
White 0.3
Black 0.2
Asian/Pacific Islander 0.1
American Indian/Alaska Native Not Shown, <16 cases
Hispanic 0.3
Non-Hispanic 0.2

U.S. 2012-2016, Age-Adjusted

Percent of Deaths by Age Group: Hodgkin Lymphoma
Age Range Percent of Deaths
<20 0.9%
20-34 9.8%
35-44 6.6%
45-54 11.1%
55-64 15.3%
65-74 21.1%
75-84 22.7%
>84 12.5%

The percent of Hodgkin lymphoma deaths is highest among people aged 75-84.

Median Age
At Death

68

U.S. 2012-2016, All Races, Both Sexes

Trends in Rates

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new Hodgkin lymphoma cases have been falling on average 1.8% each year over the last 10 years. Death rates have been falling on average 4.0% each year over 2007-2016. 5-year survival trends are shown below.

More About This Cancer

Hodgkin Lymphoma

Figure: Lymph System

Figure: Anatomy of the lymph system, showing the lymph vessels and lymph organs including lymph nodes, tonsils, thymus, spleen, and bone marrow. Lymph (clear fluid) and lymphocytes travel through the lymph vessels and into the lymph nodes where the lymphocytes destroy harmful substances. The lymph enters the blood through a large vein near the heart.

Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.

Additional Information

More Information

Here are some resources for learning more about Hodgkin lymphoma.

References

All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/hodg.html

These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.